Informations générales (source: ClinicalTrials.gov)
Clinical and Economical Evaluation of Colorectal Surgery in Ambulatory Care (Colon-Ambu)
Interventional
N/A
IHU Strasbourg (Voir sur ClinicalTrials)
janvier 2019
avril 2024
29 juin 2024
Enhanced recovery after surgery (ERAS) significantly decreases mortality, morbidity and
hospital length of stay without increasing the rate of re-hospitalization. It reduces
psychologic stress caused by surgery and decreases postoperative complications about 50
%, especially in colorectal surgery. ERAS is now the object of several Good Practices
Recommendations and is about to become the reference strategy.
The development of ambulatory surgery is a French national concern. Its interest has been
demonstrated in many surgical fields. It requires a reflection centered on the patient
and a health care pathway organization involving all health care actors.
While hospitalization is still the standard practice for colonic surgery, the objective
of this study is to evaluate the medical and economic impact of an ambulatory care for
colorectal surgery.
Ambulatory care will be compared to standard hospitalization of patients who benefit from
the ERAS program.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - 67091 - Strasbourg - France | Didier Mutter, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Male or female over 18 years old
- Patient able to understand the objectives and risks related to the trial
- Patient able to give written informed consent
- Patient able to understand and accept the health care program
- Isolated colonic lesion located on the colon or the upper rectum
- Any neoplastic or non-neoplastic colonic pathology
- Colonic surgery except resection without continuity interruption (e.g. low cecum
resection, partial colectomy, suture for polyp)
- Moderate and/or controlled comorbidities
- No history of multiple laparotomies
- No psychosocial distress
- No living alone patient
- Patient registered with the French social security
- Male or female over 18 years old
- Patient able to understand the objectives and risks related to the trial
- Patient able to give written informed consent
- Patient able to understand and accept the health care program
- Isolated colonic lesion located on the colon or the upper rectum
- Any neoplastic or non-neoplastic colonic pathology
- Colonic surgery except resection without continuity interruption (e.g. low cecum
resection, partial colectomy, suture for polyp)
- Moderate and/or controlled comorbidities
- No history of multiple laparotomies
- No psychosocial distress
- No living alone patient
- Patient registered with the French social security
- Patient in exclusion period of another clinical study
- Emergency surgical procedure
- Type 1 diabetes
- Presence of an uncontrolled preoperative anemia
- Effective anticoagulation treatment, impossible to suspend
- Kidney failure (treated by dialysis)
- Hepatic cirrhosis
- Patient refusal
- Patient in custody
- Patient under guardianship
- Pregnancy
- Breastfeeding
- Poor general condition